WP leader: Prof. Marc Maegele, Cologne
The overall aim is: to compare trauma patient coagulation, outcomes and costs in response to different existing transfusion strategies. Here we will:
Describe the costs and health outcomes associated with different patient populations and existing treatment practices.
Develop a health economic model centred on the correction of coagulopathy during patient management for use in estimating the cost-effectiveness of personalised treatment in WP8
Deliver the clinical package for WP4&5.
Deliverables |
Delivery date (month) |
Delivered | |
D3.1 | Report on centre-level comparison of existing management practices. Report detailing and comparing the site-wide variety, resource utilisation, cost and outcomes of empiric strategies for the management of trauma haemorrhage and TIC. |
16 |
√ |
Milestones |
Delivery date (month) | Delivered | |
MS19 | Patient outcomes tool set for WP8 | 16 | √ |
MS20 | Health economic model for use in WP8 | 16 |
Section of Transfusion Medicine Capital Region Blood Bank & Department of Clinical Immunology
Blegdamsvej 9
2100 København Ø
CVR: 29765774
E-mail: contact@tacticgroup.dk